Sign in to view content

LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results

Carl C. Awh, MD, FASRS

Video
Published 2018

Related

To Treat or Not to Treat: Are We Sacrificing Treatment Outcomes by Allowing Diabetic Retinopathy (DR) to Enter the Proliferative Stage?
Michael J. Elman, MD
Annual Meeting Talks
2018
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2018
Initial Results from the LADDER Trial
Carl C. Awh, MD, FASRS
Ananda Kalevar, MD, FRCS(C), DABO
Member Podcasts

Category: Instrumentation and Devices

See more